A single dose, four-way, open-label study to determine the pharmacokinetics and bioavailability of an oral suspension of combined acetaminophen and ibuprofen, a powder sachet of combined acetaminophen and ibuprofen for oral solution and two tablet formulations of combined acetaminophen and ibuprofen in 28 healthy volunteers under fasting conditions.

Trial Profile

A single dose, four-way, open-label study to determine the pharmacokinetics and bioavailability of an oral suspension of combined acetaminophen and ibuprofen, a powder sachet of combined acetaminophen and ibuprofen for oral solution and two tablet formulations of combined acetaminophen and ibuprofen in 28 healthy volunteers under fasting conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jan 2017

At a glance

  • Drugs Ibuprofen/paracetamol (Primary) ; Ibuprofen/paracetamol (Primary) ; Ibuprofen/paracetamol (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors AFT Pharmaceuticals
  • Most Recent Events

    • 04 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top